August 2019
Study identifies barriers to statin therapy adherence
Statin therapy plays a key role in preventing cardiovascular events, but many patients don’t comply with statin therapy recommendations. According to a five-year study** from the National Center for Biotechnology Information, 50% of patients don’t adhere to the recommended statin therapy, with the highest level of discontinuation happening during the first year.
The NCBI study found the following:
- Patients younger than 50 and 70 or older are more likely not to adhere.
- Women are less likely to take statins as prescribed.
- Some patients reported not understanding the reason behind or the importance of statin therapy.
- Some patients reported having trouble remembering to take their statin.
- Some patients preferred lifestyle changes, such as diet, to lower cholesterol.
By understanding the reasons for nonadherence, barriers can be addressed, and treatment plans can be tailored to meet a patient’s individual needs.
An FEP® reminder
The Federal Employee Program® encourages you to remind patients who are FEP members that that they have no copay for generic statin drugs when filled at a preferred pharmacy. If your FEP patients have questions about their benefits, they can contact Customer Service at 1‑800‑482‑3600 or visit www.fepblue.org.
**Blue Cross Blue Shield of Michigan doesn’t own or control this website.
|